AMP Members Reiterate Position on LDT Regulation; Questions to FDA Suggest Confusion Remains | GenomeWeb

NATIONAL HARBOR, Md. (GenomeWeb) — At the annual meeting of the Association for Molecular Pathology here this week, attendees gathered for a question and answer session with US Food and Drug Administration officials Alberto Gutierrez and Elizabeth Mansfield, who fielded 45 minutes of queries on the scope and details of the FDA's draft guidance on the regulation of laboratory developed tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.